NO20005352L - Paroksetinaskorbat - Google Patents
ParoksetinaskorbatInfo
- Publication number
- NO20005352L NO20005352L NO20005352A NO20005352A NO20005352L NO 20005352 L NO20005352 L NO 20005352L NO 20005352 A NO20005352 A NO 20005352A NO 20005352 A NO20005352 A NO 20005352A NO 20005352 L NO20005352 L NO 20005352L
- Authority
- NO
- Norway
- Prior art keywords
- ascorbate
- useful
- treatment
- cns disorders
- certain cns
- Prior art date
Links
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 title abstract 4
- 229940072107 ascorbate Drugs 0.000 title abstract 2
- 235000010323 ascorbic acid Nutrition 0.000 title abstract 2
- 239000011668 ascorbic acid Substances 0.000 title abstract 2
- AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 abstract 1
- AHOUBRCZNHFOSL-UHFFFAOYSA-N Paroxetine hydrochloride Natural products C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 abstract 1
- 208000015114 central nervous system disease Diseases 0.000 abstract 1
- 229960002296 paroxetine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Paroksetinaskorbat er nyttig ved behandling av visse CNS-lidelser.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9808896.6A GB9808896D0 (en) | 1998-04-25 | 1998-04-25 | Novel compound |
| PCT/GB1999/001244 WO1999055698A1 (en) | 1998-04-25 | 1999-04-23 | Paroxetine ascorbate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20005352L true NO20005352L (no) | 2000-10-24 |
| NO20005352D0 NO20005352D0 (no) | 2000-10-24 |
Family
ID=10831008
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20005352A NO20005352D0 (no) | 1998-04-25 | 2000-10-24 | Paroksetinaskorbat |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1089995A1 (no) |
| JP (1) | JP2002513019A (no) |
| KR (1) | KR20010042977A (no) |
| CN (1) | CN1297448A (no) |
| AP (1) | AP2000001963A0 (no) |
| AU (1) | AU3618499A (no) |
| BG (1) | BG104940A (no) |
| BR (1) | BR9909868A (no) |
| CA (1) | CA2330055A1 (no) |
| EA (1) | EA200001104A1 (no) |
| GB (1) | GB9808896D0 (no) |
| HU (1) | HUP0102116A3 (no) |
| ID (2) | ID26654A (no) |
| IL (1) | IL139081A0 (no) |
| NO (1) | NO20005352D0 (no) |
| PL (1) | PL343677A1 (no) |
| SK (1) | SK15912000A3 (no) |
| TR (1) | TR200003084T2 (no) |
| WO (1) | WO1999055698A1 (no) |
| ZA (1) | ZA200005912B (no) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0003232D0 (en) * | 2000-02-11 | 2000-04-05 | Smithkline Beecham Plc | Novel composition |
| IL159280A0 (en) * | 2001-06-14 | 2004-06-01 | Teva Pharma | A process for preparing paroxetine hcl which limits formation of pink colored compounds |
| EP1469827B1 (en) * | 2002-01-09 | 2017-12-27 | Emisphere Technologies, Inc. | Polymorphs of sodium 4- (4-chloro-2-hydroxybenzoyl)amino butanoate |
| CN118217851A (zh) * | 2018-10-30 | 2024-06-21 | 中国科学院化学研究所 | 一种制备粒径可调的药物或药物中间体无定型物的方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1422263A (en) * | 1973-01-30 | 1976-01-21 | Ferrosan As | 4-phenyl-piperidine compounds |
| ES2058061T3 (es) * | 1985-10-25 | 1994-11-01 | Beecham Group Plc | Derivado de piperidina, su preparacion y su uso como medicamento. |
| US5276042A (en) * | 1993-04-16 | 1994-01-04 | Crenshaw Roger T | Treatment of premature ejaculation |
| ES2117557B1 (es) * | 1996-02-29 | 1999-07-01 | Ferrer Int | Nuevo procedimiento de obtencion de (-)-trans -n-p-fluorobenzoilmetil-4-(p-fluorofenil)-3- ((3,4-(metilendioxi)fenoxi ) metil)-piperidina. |
-
1998
- 1998-04-25 GB GBGB9808896.6A patent/GB9808896D0/en not_active Ceased
-
1999
- 1999-04-23 EP EP99918151A patent/EP1089995A1/en not_active Withdrawn
- 1999-04-23 CN CN99805160A patent/CN1297448A/zh active Pending
- 1999-04-23 PL PL99343677A patent/PL343677A1/xx not_active Application Discontinuation
- 1999-04-23 TR TR2000/03084T patent/TR200003084T2/xx unknown
- 1999-04-23 ID IDW20002169A patent/ID26654A/id unknown
- 1999-04-23 BR BR9909868-7A patent/BR9909868A/pt not_active Application Discontinuation
- 1999-04-23 WO PCT/GB1999/001244 patent/WO1999055698A1/en not_active Ceased
- 1999-04-23 EA EA200001104A patent/EA200001104A1/ru unknown
- 1999-04-23 AU AU36184/99A patent/AU3618499A/en not_active Abandoned
- 1999-04-23 ID IDW20002168A patent/ID26083A/id unknown
- 1999-04-23 JP JP2000545858A patent/JP2002513019A/ja active Pending
- 1999-04-23 SK SK1591-2000A patent/SK15912000A3/sk unknown
- 1999-04-23 CA CA002330055A patent/CA2330055A1/en not_active Abandoned
- 1999-04-23 AP APAP/P/2000/001963A patent/AP2000001963A0/en unknown
- 1999-04-23 HU HU0102116A patent/HUP0102116A3/hu unknown
- 1999-04-23 KR KR1020007011809A patent/KR20010042977A/ko not_active Withdrawn
- 1999-04-23 IL IL13908199A patent/IL139081A0/xx unknown
-
2000
- 2000-10-23 ZA ZA200005912A patent/ZA200005912B/en unknown
- 2000-10-24 NO NO20005352A patent/NO20005352D0/no not_active Application Discontinuation
- 2000-11-13 BG BG104940A patent/BG104940A/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1297448A (zh) | 2001-05-30 |
| HUP0102116A2 (hu) | 2002-05-29 |
| HUP0102116A3 (en) | 2002-12-28 |
| GB9808896D0 (en) | 1998-06-24 |
| IL139081A0 (en) | 2001-11-25 |
| WO1999055698A1 (en) | 1999-11-04 |
| AU3618499A (en) | 1999-11-16 |
| JP2002513019A (ja) | 2002-05-08 |
| TR200003084T2 (tr) | 2001-02-21 |
| CA2330055A1 (en) | 1999-11-04 |
| BR9909868A (pt) | 2000-12-19 |
| ZA200005912B (en) | 2001-12-19 |
| AP2000001963A0 (en) | 2000-12-31 |
| ID26654A (id) | 2001-01-25 |
| SK15912000A3 (sk) | 2001-04-09 |
| EP1089995A1 (en) | 2001-04-11 |
| ID26083A (id) | 2000-11-23 |
| KR20010042977A (ko) | 2001-05-25 |
| EA200001104A1 (ru) | 2001-04-23 |
| PL343677A1 (en) | 2001-08-27 |
| BG104940A (bg) | 2001-09-28 |
| NO20005352D0 (no) | 2000-10-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO993051L (no) | Intranasale formuleringer for behandling av seksuelle forstyrrelser | |
| ID30062A (id) | Alanog-analog benzopiran tersubstitusi untuk pengobatan radang | |
| DE60022917D1 (de) | Reboxetin zur Behandlung von Migränekopfschmerzen | |
| DE60124684D1 (de) | Sulfonamido-substituierte verbrückte bicycloalkylderivative | |
| NO20005885D0 (no) | Kombinasjonsterapi for behandling av refraktær depresjon | |
| NO20005884D0 (no) | Kombinasjonsterapi for behandling av bipolare forstyrrelser | |
| PT889886E (pt) | Novas fenantridinas substituidas na posicao 6 | |
| NO20005032L (no) | Behandling av parasittsykdommer ved inhibering av cysteinproteaser av papainsuperfamilien | |
| NO20014617L (no) | 1-Arensulfonyl-2-aryl-pyrrolidin- og -piperidin-derivater for behandling av CNS-sykdommer | |
| EE200000093A (et) | Agrekanaasi ja maatriksmetalloproteinaaside uudsed inhibiitorid artriidi käitlemiseks | |
| YU48698A (sh) | Karboksamidni derivati pirolidina, piperidina i heksahidroazepina za lečenje oboljenja na bazi tromboze | |
| ID27214A (id) | Triazolopiridina untuk pengobatan gangguan trombosis | |
| NO20003211D0 (no) | Triazinforbindelser for behandling av CNS forstyrrelser | |
| NO984432L (no) | FremgangsmÕte for behandling av migrenesmerte | |
| NO20005352L (no) | Paroksetinaskorbat | |
| BR0012921A (pt) | Compostos calcilìticos | |
| DE60133385D1 (de) | (+)-alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-4-piperidinemethanol oder prodrug davon zur behandlung von demenzsymptomen oder kognitiven störungen | |
| NO990450D0 (no) | Behandling av sinnslidelser | |
| SG148840A1 (en) | Indole derivatives useful for the treatment of cns disorders | |
| NO20011892D0 (no) | 3-tetrahydropyridin-4-yl-indoler for behandling av psykotiske forstyrrelser | |
| DK1133296T3 (da) | Ny terapeutisk anvendelse af nicergolin | |
| NO20010390D0 (no) | Behandling av angstsykdommer | |
| NO20010569D0 (no) | Proteaseinhibitorer for anvendelse ved behandling av psoriasis | |
| NO20005037L (no) | Paroksetinmaleat | |
| DE69917445D1 (de) | Reinigung von carboxaldehyd |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |